These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20820656)

  • 21. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.
    Jansen RW; Kruijt JK; van Berkel TJ; Meijer DK
    Hepatology; 1993 Jul; 18(1):146-52. PubMed ID: 7686877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Boc-histidine-capped PLGA-PEG-PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pH.
    Chang G; Li C; Lu W; Ding J
    Macromol Biosci; 2010 Oct; 10(10):1248-56. PubMed ID: 20593367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-labile core cross-linked micelles for pH-triggered release of antitumor drugs.
    Chan Y; Wong T; Byrne F; Kavallaris M; Bulmus V
    Biomacromolecules; 2008 Jul; 9(7):1826-36. PubMed ID: 18564874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable click capsules with engineered drug-loaded multilayers.
    Ochs CJ; Such GK; Yan Y; van Koeverden MP; Caruso F
    ACS Nano; 2010 Mar; 4(3):1653-63. PubMed ID: 20201548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.
    Karve S; Alaouie A; Zhou Y; Rotolo J; Sofou S
    Biomaterials; 2009 Oct; 30(30):6055-64. PubMed ID: 19665223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity.
    Karve S; Bandekar A; Ali MR; Sofou S
    Biomaterials; 2010 May; 31(15):4409-16. PubMed ID: 20189243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
    Xiangyang X; Ling L; Jianping Z; Shiyue L; Jie Y; Xiaojin Y; Jinsheng R
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):222-8. PubMed ID: 17254755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response.
    Zhang J; Misra RD
    Acta Biomater; 2007 Nov; 3(6):838-50. PubMed ID: 17638599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker.
    Ding C; Gu J; Qu X; Yang Z
    Bioconjug Chem; 2009 Jun; 20(6):1163-70. PubMed ID: 19472997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fullerene-conjugated doxorubicin in cells.
    Liu JH; Cao L; Luo PG; Yang ST; Lu F; Wang H; Meziani MJ; Haque SA; Liu Y; Lacher S; Sun YP
    ACS Appl Mater Interfaces; 2010 May; 2(5):1384-9. PubMed ID: 20420365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fullerenol-cytotoxic conjugates for cancer chemotherapy.
    Chaudhuri P; Paraskar A; Soni S; Mashelkar RA; Sengupta S
    ACS Nano; 2009 Sep; 3(9):2505-14. PubMed ID: 19681636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New amphiphilic carriers forming pH-sensitive nanoparticles for nucleic acid delivery.
    Xu R; Wang XL; Lu ZR
    Langmuir; 2010 Sep; 26(17):13874-82. PubMed ID: 20672851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
    Etrych T; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiro Diorthoester (SpiDo), a Human Plasma Stable Acid-Sensitive Cleavable Linker for Lysosomal Release.
    Leriche G; Nothisen M; Baumlin N; Muller CD; Bagnard D; Remy JS; Jacques SA; Wagner A
    Bioconjug Chem; 2015 Aug; 26(8):1461-5. PubMed ID: 26131605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.